Quinlan Paul T
Quinlan Paul T is a corporate insider (General Counsel) at TerraVia Holdings, Inc. (TVIA) filing SEC Form 4 transactions. 168 transactions across 3 companies, totaling $0 in purchases and $3,200,614 in sales. Source: SEC EDGAR.
Insider trading profile for Quinlan Paul T across three companies: (1) TerraVia Holdings (TVIA): 117 tx 2012-2017, 519K SELL (legacy, pre-acquisition/reorganization). (2) CymaBay Therapeutics (CBAY): 49 tx 2018-2024. M-code 5K batches at $2.94 exercise, S-code 5K sells at $13-$23; D-code distribution Mar 2024 totaling 720K+ shares distributed. (3) Oruka Therapeutics (ORKA): 2 tx. Jan 2025 A-code 162,500 shares at $12.50; Jun 2026 S-code 733 at $69.69. Key signal: ORKA A-code at $12.50 (Jan 2025) vs current $69.69 represents a 5.6x gain; the small S-code at $69.69 suggests partial profit-taking. CBAY D-code (distribution) of 720K+ shares in March 2024 is a one-time event (e.g., spin-off, merger distribution). Mixed -- biotech insider with consistent sell patterns at legacy names; ORKA shows large gain with early partial liquidation.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Sale | 733 | $69.69 | $51K | 31,034 | 6/15/2026 Filed: 6/15/2026 | Filing → | |
| Award | 162,500 | $12.50 | $2.03M | 162,500 | 1/22/2025 Filed: 1/24/2025 | Filing → | |
CymaBay Therapeutics, Inc. CBAY | Disposition | 105,625 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 215,000 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 107,000 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 22,167 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 233,176 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 28,438 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 41,824 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Exercise | 41,824 | - | - | 8,872 | 3/13/2024 Filed: 3/15/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Exercise | 41,824 | $7.89 | $330K | 70,262 | 3/13/2024 Filed: 3/15/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Award | 105,625 | - | - | 105,625 | 1/24/2024 Filed: 1/26/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Award | 28,438 | - | - | 28,438 | 1/24/2024 Filed: 1/26/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Exercise | 5,000 | - | - | 107,000 | 1/16/2024 Filed: 1/16/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Sale | 5,000 | $23.58 | $118K | 0 | 1/16/2024 Filed: 1/16/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Exercise | 5,000 | $2.94 | $15K | 5,000 | 1/16/2024 Filed: 1/16/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Exercise | 5,000 | $0.00 | $0 | 112,000 | 12/15/2023 Filed: 12/15/2023 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Sale | 5,000 | $21.98 | $110K | 0 | 12/15/2023 Filed: 12/15/2023 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Exercise | 5,000 | $2.94 | $15K | 5,000 | 12/15/2023 Filed: 12/15/2023 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Exercise | 5,000 | $0.00 | $0 | 117,000 | 11/15/2023 Filed: 11/17/2023 | Filing → |
Try asking...